Niacin Side Effects: From Flushing to Liver Toxicity

Flushing, a sudden warmth and redness of the face and upper body, is by far the most common side effect of niacin (vitamin B3), but it is hardly the only one. Depending on the dose, the formulation, and how long you take it, niacin can affect your liver, blood sugar, skin, eyes, and even your uric acid levels. Most of these effects are manageable or reversible, yet some are serious enough that two large clinical trials were stopped or produced cautionary findings. Understanding which side effects are merely annoying and which deserve real attention can help you have a more informed conversation with your doctor if niacin is part of your treatment plan.

The Flush and Why It Happens

If you have ever taken a therapeutic dose of niacin and felt your face and neck turn hot, red, and tingly within 20 or 30 minutes, you have experienced the niacin flush. It is not an allergic reaction. The flush happens because niacin activates a specific receptor on immune cells in the skin called Langerhans cells. When those cells are stimulated, they release prostaglandins D2 and E2, which dilate blood vessels near the surface and produce that characteristic warmth and redness.¹ The flush typically peaks in the first few weeks of treatment and then fades as your body adjusts, but it never fully disappears for everyone, and it is the single biggest reason people quit taking the drug.

A few practical strategies reduce flushing. Taking niacin at bedtime with a small snack helps, because you sleep through the worst of it. Taking an aspirin or another NSAID about 30 minutes beforehand blunts the prostaglandin response and meaningfully reduces symptoms.² Avoiding hot beverages, alcohol, and spicy food around the time you take your dose also helps, since anything that dilates blood vessels on its own will amplify the flush. Extended-release formulations were developed partly to soften the peak of flushing by spreading absorption over several hours, and they do reduce it compared to immediate-release pills, though they introduce a different risk profile discussed below.

Laropiprant and the Attempt to Eliminate Flushing

Because flushing is primarily driven by prostaglandin D2, researchers developed laropiprant, a drug that blocks the receptor (DP1) where prostaglandin D2 acts. In clinical studies, combining extended-release niacin with laropiprant cut flushing substantially: roughly 20% of patients on the combination experienced moderate-to-severe flushing, compared to about 49% of those on niacin alone.³ The degree of flushing also varies between individuals, and laropiprant helped across different populations.⁴

The combination looked promising until the HPS2-THRIVE trial, one of the largest niacin trials ever conducted, revealed a series of unexpected safety problems. While flushing was indeed reduced, the niacin-laropiprant combination was associated with increased rates of serious infections, bleeding, new diabetes diagnoses, gastrointestinal and musculoskeletal problems, and skin adverse events.⁵ These harms had not been seen in earlier, smaller trials. Pooled analyses of those earlier studies had found that the safety profiles of the combination and niacin alone were similar aside from less flushing with the combination.⁶ It took the much larger HPS2-THRIVE trial to expose the signal. Whether laropiprant itself contributed to the harms or whether the combination simply kept patients on high-dose niacin long enough for its toxicity to accumulate remains debated, but the product was withdrawn from markets worldwide. Aspirin remains the main over-the-counter option for managing flushing, though it is less effective than laropiprant was.⁷

Liver Toxicity and the Formulation Problem

Niacin’s effect on the liver depends heavily on which formulation you take, and this is where a common misconception causes real harm. Sustained-release (SR) niacin, the kind often sold over the counter, is significantly more hepatotoxic than immediate-release (IR) niacin. In one head-to-head comparison, 52% of patients on the sustained-release form developed liver toxicity, while none of the patients on the immediate-release form did.⁸ The sustained-release group also had dramatically higher dropout rates: 78% of patients couldn’t finish the dose escalation to 3,000 mg per day because of gastrointestinal symptoms, fatigue, and rising liver enzymes.

The irony is that sustained-release niacin was developed to reduce flushing, and it does. But the tradeoff is a formulation that is far harder on the liver. Prescription extended-release niacin (such as Niaspan) occupies a middle ground with a more controlled release profile than over-the-counter SR products, but liver monitoring is still standard. If you buy niacin supplements at a drugstore, the label may not clearly distinguish between sustained-release and immediate-release, so this is worth paying attention to. The general guidance is that over-the-counter sustained-release niacin at high doses should be avoided, and any therapeutic niacin use should involve periodic liver-function blood tests.

Blood Sugar and Diabetes Risk

Niacin raises blood sugar. The effect is typically modest, but it is real and consistent across studies. In the ADMIT trial, a randomized study of patients with peripheral arterial disease, niacin increased glucose levels by about 8.7 mg/dL in participants who already had diabetes, and by about 6.3 mg/dL in those without diabetes. It also raised HbA1c (a marker of longer-term blood sugar control) by 0.3 percentage points in diabetic patients.⁹ Short-term trials have shown that niacin induces some degree of insulin resistance, though the clinical response in most people is minor.¹⁰

A combined analysis of four lipid trials found that while niacin did shift glucose levels upward, it did not significantly change insulin levels, and the direction of the glucose change didn’t necessarily translate into worse clinical outcomes for people whose blood sugar was normal at baseline.¹¹ The bigger concern showed up in the HPS2-THRIVE trial, where niacin (combined with laropiprant) was associated with 1.3 percentage points more new diabetes diagnoses and 3.7 percentage points more serious disturbances in diabetes control compared to placebo.¹² For someone with prediabetes or existing diabetes, the blood sugar impact of niacin is worth monitoring closely, even if it is not a reason by itself to avoid the drug.

What the Big Trials Found About Cardiovascular Outcomes

The AIM-HIGH trial tested whether adding extended-release niacin to statin therapy would reduce heart attacks, strokes, and related events in patients who already had well-controlled LDL cholesterol. It did not. Despite raising HDL cholesterol and lowering triglycerides as expected, niacin added no measurable cardiovascular benefit over statins alone. The trial was stopped after three years for futility.¹³

Beyond the lack of benefit, a secondary analysis of the AIM-HIGH data raised a worrying signal about stroke. The niacin group had roughly 1.86% ischemic strokes compared to 1.06% in the placebo group. After adjusting for risk factors like age and history of prior strokes, the association between niacin and ischemic stroke fell just short of statistical significance, but it was enough to attract attention.¹⁴ HPS2-THRIVE similarly found no cardiovascular benefit and layered on its own set of serious adverse effects, including the previously unrecognized risks of bleeding and infection.¹⁵

Together, these two trials fundamentally changed how niacin is used. Before AIM-HIGH and HPS2-THRIVE, niacin was widely prescribed as a second-line lipid drug added on top of statins. Now most guidelines reserve it for narrow situations, like patients who truly cannot tolerate statins or who have specific lipid abnormalities (very high triglycerides, for example) that other drugs do not adequately address.

Skin Effects Beyond the Flush

Flushing gets most of the attention, but niacin can cause other skin changes. One of the more notable is acanthosis nigricans, a darkening and thickening of the skin, especially in folds around the neck, armpits, and groin. A systematic review of drug-induced cases found that nicotinic acid (niacin) and insulin were the two most frequently reported causes of this condition.¹⁶ This is likely related to niacin’s effect on insulin resistance, since acanthosis nigricans is strongly associated with insulin resistance from any cause. It is generally reversible when the drug is stopped, but if you notice these skin changes while taking niacin, it is worth mentioning to your doctor because it may signal a metabolic shift worth investigating.

Some patients also experience itching, rashes, or dry skin that persist beyond the acute flushing episode. These are less well studied but commonly reported, and they contribute to the high rate of people who simply stop taking niacin.

Eye Problems at High Doses

A less common but clinically significant side effect is niacin-related macular edema, a swelling in the central part of the retina that can blur your vision. Case reports have documented this occurring even at relatively low therapeutic doses. In one reported case, imaging showed retinal thickening and fluid-filled cysts in both eyes. Importantly, the edema resolved completely within about four weeks of stopping niacin, with visual acuity improving in both eyes and normal retinal structure returning.¹⁷ The mechanism is not entirely clear, but it appears to involve vascular changes in the retina without the kind of leakage seen in other causes of macular edema.

This side effect is uncommon enough that routine eye exams are not typically required for niacin users, but anyone taking the drug who notices blurred or distorted central vision should have it checked promptly. The reversibility is reassuring, but only if the drug is actually stopped in time.

Blood Pressure, Dizziness, and Drug Interactions

Niacin can lower blood pressure, which makes sense given that it dilates blood vessels (the same mechanism behind the flush). For most people this is negligible, but prescription niacin formulations carry warnings about rare cases of syncope (fainting), hypotension, and postural hypotension, particularly when niacin is taken alongside blood-pressure-lowering medications or other vasoactive drugs.¹⁸ If you already take medication for high blood pressure or use nitrates for chest pain, the combination with niacin deserves extra caution, especially when standing up quickly.

What Happens in an Overdose

Niacin overdoses are uncommon but have been documented, sometimes in people who took massive doses in an attempt to pass a urine drug screen. In a case series of patients who used niacin for this purpose, two had only skin flushing, but the other two developed life-threatening symptoms including nausea, vomiting, liver damage, metabolic acidosis, and swings between low and high blood sugar. One patient also had abnormal heart rhythm changes.¹⁹ In another case, a 56-year-old man who ingested 11,000 mg of niacin developed severe, persistent low blood pressure that required 12 hours of intravenous medication to stabilize. Interestingly, he did not develop flushing at all, suggesting that at extreme doses the cardiovascular collapse pathway can dominate over the typical skin response.²⁰ All patients in these reports recovered with supportive care, but the cases underline that niacin is not as harmless as its vitamin status might suggest.

The Nicotinic Acid Versus Nicotinamide Distinction

Niacin (nicotinic acid) and nicotinamide (niacinamide) are both forms of vitamin B3, but they have very different side-effect profiles and very different clinical uses. Nicotinic acid is the form that affects cholesterol, causes flushing, and carries all of the risks discussed so far. Nicotinamide does not cause flushing and does not have significant effects on lipids. It has been studied mainly for diabetes prevention and certain skin conditions.

Nicotinamide has its own toxicity ceiling, though. At adult doses above about 3,000 mg per day, reversible liver toxicity has been reported in both animal and human studies. Minor liver enzyme elevations can occasionally occur even at the lower doses used in diabetes prevention research. The drug is generally well tolerated at standard doses, but unsupervised high-dose use carries real hepatotoxic potential. If you are taking a B3 supplement, knowing which form you have matters. The names are confusingly similar, and product labels do not always make the distinction obvious.

Why So Many People Stop Taking Niacin

The real-world dropout rate for niacin is strikingly high, especially compared to how it looks in clinical trials. In a study comparing drug discontinuation between randomized trials and actual primary care settings, the probability of stopping niacin within one year was 46% in routine medical practice, compared to only about 4% in clinical trials.²¹ That gap is enormous and reflects something important: in a clinical trial, patients receive close follow-up, careful dose titration, coaching on how to manage flushing, and motivation from being part of a study. In a regular doctor’s office, many patients pick up a prescription or supplement, experience an unpleasant flush, maybe some stomach upset, and simply stop.

By comparison, statin discontinuation at one year in the same study was about 15%. Niacin’s adherence problem is not just academic. A drug’s side-effect profile matters most in terms of whether people actually tolerate it long enough for any potential benefit to accrue. For niacin, the gap between theoretical efficacy and real-world use is wider than for almost any other lipid-lowering medication, and the side effects are the primary reason.

Niacin During Pregnancy

There is very little data on niacin use during pregnancy, which means most clinicians avoid it. However, rare cases have documented its use in pregnant women with dangerously high triglyceride levels who were at risk for pancreatitis. In one published case, a woman with triglycerides above 3,000 mg/dL was started on niacin at up to 2,000 mg per day, which successfully kept her levels below 1,000 mg/dL through the rest of the pregnancy. The authors noted that niacin is often underutilized in pregnancy because of perceived risks, and argued that in cases of severe hypertriglyceridemia where other treatments are inadequate, niacin can be both effective and tolerable. Still, a single case report is a very thin evidence base. Niacin in pregnancy remains something that would only be considered in extreme circumstances where the risk of not treating (such as pancreatitis) outweighs the unknowns.

Uric Acid and Gout

Niacin can raise uric acid levels, which is a concern for anyone with a history of gout or kidney stones made of uric acid. The mechanism is thought to involve competition for the same excretion pathways in the kidneys, meaning the body clears uric acid less efficiently when niacin is present. This effect is dose-dependent and usually appears at therapeutic lipid-lowering doses rather than at the amounts found in multivitamins. If you are prone to gout flares, niacin therapy might tip you over the edge, so your uric acid levels should be monitored. This side effect is not rare but gets less attention than flushing or liver toxicity because it only affects a subset of patients with a specific vulnerability.

Gastrointestinal Complaints

Nausea, vomiting, diarrhea, and general stomach discomfort are common enough that gastrointestinal symptoms were one of the leading reasons patients dropped out of the sustained-release niacin group in the head-to-head formulation trial.²² These symptoms tend to be worse at higher doses and during dose escalation, which is why guidelines recommend starting low and increasing gradually over weeks. Taking niacin with food helps. The gastrointestinal effects are generally less formulation-dependent than liver toxicity: both immediate-release and sustained-release niacin can cause stomach problems, though the sustained-release form may be somewhat worse because it delivers a steady load to the gut lining over several hours.